ClinicalTrials.gg
Not yet recruitingNCT07176520Updated Sep 16, 2025

AI-Assisted Rehabilitation In Frailty

An interventional study of AI-assisted rehabilitation and usual care only in Frail, sponsored by SingHealth Community Hospitals. Not yet recruiting. Open to participants aged 21 Years to 120 Years. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by SingHealth Community Hospitals · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Randomized
Ages
21 Years to 120 Years
Sex
All
01

Study summary

This study investigates the effectiveness and implementation of an AI-assisted rehabilitation tool for adults with frailty in the real-world. The main questions it aims to answer are:

Does AI-assisted rehabilitation among frail adults improve patients' physical outcomes? Is there a particular subgroup of frail subjects that will benefit most from AI-assisted rehabilitation?

Researchers will compare AI-assisted rehabilitation to standard practice (advice and QR link for rehabilitation videos to be done at home) to see if AI-assisted rehabilitation improves clinical outcomes compared to standard practice.

Participants will either:

Undergo an AI-assisted rehab with the AI-sensor tool or a standard practice post-discharge from community hospitals for 12 weeks.

Undergo interval assessments of outcomes. Keep a diary of outpatient rehabilitations (if applicable for the subjects).

Read the detailed description

This is a pragmatic, randomized controlled study on frail patients discharged from three community hospitals in Singapore.

02

Conditions studied

  • Frail

Keywords

  • hybrid effectiveness-implementation study
  • pragmatic
03

In context

Lead sponsor

SingHealth Community Hospitals is the lead sponsor of 5 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 120 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged ≥ 21years
  • Clinical Frailty Score (CFS) 4 to 6 *
  • Provided (for cognitively impaired persons \<18, next-of-kin or proxy to give consent).
  • Have access to smartphone/tablet (own or loaned from investigators)/

Exclusion criteria

Exclusion Criteria:

  • Medical conditions precluding safe home exercises or severely affect interaction with AI-tool (angina, vision loss, hearing impairment).
  • Cognitive impairment (\<18) and no caregiver to assist with use of tool.
  • Participation in structured outpatient physiotherapy (>1 times/week), or day rehab programme.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Care provider, Investigator, Outcomes assessor)
Enrollment
220 participants (estimated)

Study arms

  • Other
    Usual care

    Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)

    Other: usual care only

  • Active comparator
    AI-assisted rehabilitation

    AI-assisted rehabilitation on top of usual care

    Device: AI-assisted rehabilitation

Interventions

  • DeviceAI-assisted rehabilitation

    Receives AI-assisted rehabilitation post-discharge at home in addition to usual care

  • Otherusual care only

    Verbal and written discharge summary, advice, and referral to outpatient physiotherapy (if applicable)

06

What researchers measure

Primary outcomes

  1. Absolute Functional Gain (AFG)

    AFG= Functional score (at discharge/follow-up points) - functional score (at admission). Functional score is based on Modified Barthel Index (MBI).

    Time frame: baseline, 3, 6, 9 and 12 weeks.

Secondary outcomes

  1. Functional outcome: Short Physical Performance Battery (SPBB)

    SPBB is a validated and commonly used tool to evaluate physical performance particularly in older adults. It is based on three timed tasks: gait speed (over short distance of 4 metres), balance tests (side-by-side, semi-tandem, and full-tandem), and repetitive chair sit-to-stand (strength and endurance) performance.45 It is an indicator of vulnerability, is associated with readmissions, and predictive of all-cause mortality.

    Time frame: baseline, 3, 6, 9, 12-weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — In accordance to my ethical board and institutional requirements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2025; primary completion for Jan 2027, 13 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2025
First posted
Sep 16, 2025
StartEst.
Dec 1, 2025
Primary completionEst.
Jan 31, 2027
CompletionEst.
Apr 30, 2027
Last update
Sep 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07176520
Lead sponsor
SingHealth Community Hospitals
Collaborators
Jurong Community Hospital, Singapore
Responsible party
Ong Chong Yau (Doctor, SingHealth Community Hospitals) — Principal investigator
First posted
Sep 16, 2025
Start date
Dec 1, 2025 (estimated)
Primary completion
Jan 31, 2027 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Sep 16, 2025

Study contacts

Chong Yau Clinical Asst Professor, MBBS
Contact
ong.chong.yau@singhealth.com.sg
6569703000

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion